Transcriptome screening identifies TIPARP as an antiviral host factor against the Getah virus

J Virol. 2023 Oct 31;97(10):e0059123. doi: 10.1128/jvi.00591-23. Epub 2023 Sep 28.

Abstract

Alphaviruses threaten public health continuously, and Getah virus (GETV) is a re-emerging alphavirus that can potentially infect humans. Approved antiviral drugs and vaccines against alphaviruses are few available, but several host antiviral factors have been reported. Here, we used GETV as a model of alphaviruses to screen for additional host factors. Tetrachlorodibenzo-p-dioxin-inducible poly(ADP ribose) polymerase was identified to inhibit GETV replication by inducing ubiquitination of the glycoprotein E2, causing its degradation by recruiting the E3 ubiquitin ligase membrane-associated RING-CH8 (MARCH8). Using GETV as a model virus, focusing on the relationship between viral structural proteins and host factors to screen antiviral host factors provides new insights for antiviral studies on alphaviruses.

Keywords: GETV; TIPARP; alphavirus; antiviral factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphavirus* / growth & development
  • Alphavirus* / immunology
  • Glycoproteins / metabolism
  • Host Microbial Interactions*
  • Humans
  • Nucleoside Transport Proteins* / genetics
  • Nucleoside Transport Proteins* / metabolism
  • Poly(ADP-ribose) Polymerases* / genetics
  • Poly(ADP-ribose) Polymerases* / metabolism
  • Transcriptome*
  • Ubiquitination
  • Viral Structural Proteins / metabolism
  • Virus Replication

Substances

  • Glycoproteins
  • MARCHF8 protein, human
  • Nucleoside Transport Proteins
  • Poly(ADP-ribose) Polymerases
  • TiPARP protein, human
  • Viral Structural Proteins